Kennedy Capital Management’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.2M | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $1.41M | Sell |
|
|||||
|
2023
Q4 | $2.47M | Sell |
|
|||||
|
2023
Q3 | $2.41M | Buy |
|
|||||
|
2023
Q2 | $2.96M | Buy |
|
|||||
|
2023
Q1 | $2.93M | Buy |
|
|||||
|
2022
Q4 | $3.62M | Sell |
|
|||||
|
2022
Q3 | $2.29M | Buy |
|
|||||
|
2022
Q2 | $656K | Sell |
|
|||||
|
2022
Q1 | $835K | Sell |
|
|||||
|
2021
Q4 | $1.09M | Buy |
|